Enforcement: OIG Utilizes Providers' Data in Biggest Fraud Takedown Ever

Why This Topic Matters

It shows how federal enforcement activity can affect providers, vendors, and compliance programs, especially where claims data, prescribing patterns, and health IT systems are involved.

Article Sections

1. OIG semiannual report overview

   Introduces the report’s enforcement focus and the role of data-driven oversight in identifying fraud trends and vulnerabilities. Summarizes the overall scope of the agency’s activities during the reported fiscal year.

2. FY 2017 enforcement results

   Presents a high-level summary of recoveries, criminal actions, civil actions, and exclusions reported for the fiscal year. The section frames the scale of the agency’s enforcement activity.

3. National Health Care Fraud Takedown and opioid-related enforcement

   Describes the large interagency takedown and related opioid enforcement actions highlighted in the report. Focuses on broad categories of conduct and the agencies’ use of provider data.

4. Selected enforcement examples

   Provides representative examples from the report involving home health, health IT, and drug-related investigations. The section illustrates the types of cases the OIG featured in its summary.

5. Home health

   Covers one of the report’s home health enforcement matters and associated sentencing and restitution information. The discussion is limited to the broad case category and outcome context.

6. EHR vendor certifications

   Addresses enforcement involving an electronic health record vendor and related provider claim issues. The section highlights the intersection of health IT compliance and federal oversight.

7. Other opioid enforcements

   Summarizes additional opioid-related enforcement actions referenced in the report. The section groups together multiple cases and related agency actions.